Targeting CDCP1 boost CD8+ T cells-mediated cytotoxicity in cervical cancer via the JAK/STAT signaling pathway
CDCP1 plays a critical role in cervical cancer progression by modulating the tumor immune microenvironment. Targeting CDCP1 offers a promising therapeutic strategy to improve the outcome of patients with cervical cancer.
Authors
- Tianyu Liu (ORCID: https://orcid.org/0000-0001-9121-9021)
- Shuzhong Yao (ORCID: https://orcid.org/0000-0002-5145-5705)
- Chao Pan (ORCID: https://orcid.org/0000-0002-0912-5171)
- Jiaming Huang (ORCID: https://orcid.org/0000-0002-0725-9782)
- Yijia Zhou
- Qiqiao Du (ORCID: https://orcid.org/0000-0003-4053-1044)
- Yuwen Pan
- Qiaojian Zou
- Shuhang Qin (ORCID: https://orcid.org/0000-0001-8613-3610)
- Junxiu Liu (ORCID: https://orcid.org/0000-0002-7892-6343)
- Yuandong Liao
- Jie Li (ORCID: https://orcid.org/0000-0001-6165-2668)
- Chunyu Zhang (ORCID: https://orcid.org/0000-0003-1935-6907)
- Yuan Li (ORCID: https://orcid.org/0000-0002-1683-6801)
- Yili Chen (ORCID: https://orcid.org/0000-0002-1409-631X)
- Yanchun Liang (ORCID: https://orcid.org/0009-0009-3069-5660)
- Qiuwen Mai (ORCID: https://orcid.org/0000-0002-9039-9435)
- Hua Huang (ORCID: https://orcid.org/0000-0002-1713-8597)
- Wei J. Wang (ORCID: https://orcid.org/0000-0002-4848-7394)
Institutions
- Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Journal for ImmunoTherapy of Cancer
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1136/jitc-2024-009416
- Citations
- 13
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.67
Funders
- National Natural Science Foundation of China